Atlas Trials

Semaglutide 2.4mg for Low Responders After Bariatric Surgery

Clinical trial NCT06287307 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06287307
Sponsor
Zuyderland Medisch Centrum
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
ObesityObesity, MorbidWeight Gain
Start date
2024-05-01
Primary completion
2026-02-01
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.